Therapy Areas: Oncology
Adcentrx Therapeutics' ADRX-0405 IND application approved by US FDA
22 October 2024 - California-based clinical-stage biotechnology company Adcentrx Therapeutics announced on Monday that it has received approval from the US Food and Drug Administration (FDA) for the c...
BeiGene secures positive CHMP opinions for TEVIMBRA in gastric, gastroesophageal and esophageal cancers
21 October 2024 - Oncology company BeiGene Ltd (NASDAQ: BGNE) (HKEX: 06160) (SSE: 688235) announced on Monday that it has received positive recommendations from the European Medicines Agency's Co...
Avacta Group partners with Tempus to enhance AI-driven oncology drug development
21 October 2024 - Life sciences company Avacta Group revealed on Monday that its clinical stage oncology biotech division Avacta Therapeutics Avacta Therapeutics (AIM: AVCT) has entered into a strateg...
Novartis receives positive CHMP opinion for Kisqali
18 October 2024 - Swiss pharmaceutical company Novartis Pharma AG (SIX:NOVN) (NYSE:NVS) announced on Friday that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Age...
OncoZenge partners with Pharmanovia for exclusive BupiZenge commercialization in EMENA regions
18 October 2024 - Pharmaceutical company OncoZenge AB (publ) (STO:ONCOZ) announced on Friday plans to partner with Pharmanovia for exclusive commercialization rights of BupiZenge in Europe, the Middle...
SHINE Technologies collaboration could result in new kidney and prostate cancer treatments
18 October 2024 - Next-generation fusion company SHINE Technologies and WARF Therapeutics, a drug discovery programme from the Wisconsin Alumni Research Foundation (WARF), announced on Thursday promis...